Making the Connection: A Modern Approach to the Treatment of Type 1 & Type 2 Diabetes (May 11, 2019)

Making the Connection: A Modern Approach to the Treatment of Type 1 & Type 2 Diabetes is organized by Taking Control of Your Diabetes (TCOYD) and will be held on May 11, 2019 at Raleigh Convention Center, Raleigh, North Carolina, United States of America.

Target Audience:
This course is designed for diabetes healthcare providers including endocrinologists, primary care physicians, nurse practitioners, physician assistants, nurses, certified diabetes educators, pharmacists, and other healthcare providers wanting to expand their knowledge of diabetes management.

Accreditation:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Uni­versity of California, San Diego School of Medicine and Taking Control of Your Diabetes. The University of California, San Diego School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

AMA:
The University of California, San Diego School of Medicine designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses:
For the purposes of recertification, the American Nurses Credentialing Center accepts AMA PRA Cate­gory 1 Credits™ issued by organizations accredited by the ACCME. For the purpose of re-licensure, the Califor­nia Board of Registered Nursing accepts AMA PRA Category 1 credits™ (report up to 5.75 hours of credit and list “CME Category 1” as the provider number).

Physician Assistants:
The AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Phy­sician assistants may receive a maximum of 5.75 hours of Category 1 credit for completing this program.

Credit Designation:
Global Education Group designates this continuing education activity for 5.75 contact hour(s) (0.65 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0530-999-18-422-L01-P).

Course Description:
This activity for clinicians will focus on four distinct areas of diabetes management and will integrate case presentations into the lectures in order to facilitate more active audience participation. The four areas are:
• Patient-provider relationships with a focus on communication methods to improve adherence and persistence
• Oral agents for the treatment of type 2 diabetes and their effect on cardiovascular health
• Injectable therapies, including insulin, for use in patients with type 2 diabetes
• New and emerging strategies for patients with type 1 diabetes.

In addition, this course is held in tandem with a separate, large-scale patient-focused conference. This will give providers the opportunity to observe and interact with people who have had diabetes and are engaged in their own intensive educational environment. By making that connection with patients, providers will acquire new skills and insight into what empowers patients with diabetes to develop healthy self-management of their condition. 

The ultimate goal of this CME conference is to educate caregivers and clinicians about the most effective cutting-edge strategies to help patients with type 1 and type 2 diabetes reach their treatment goals and avoid the associated acute and chronic complications. FAR FROM BORING, these aren’t your typical CME lectures. We promise to infuse a little HUMOR, some good eats and interesting interaction along the way.

Learning Objectives:
At course completion, participants should be able to:
• Identify the different pathophysiologic defects associated with type 2 diabetes and how all the pharmacologic agents (oral and injectable) address these specific abnormalities.
• Review the recently published cardiovascular outcome trials (CVOTs) on oral and injectable type 2 medications.
• Discuss the implications of recently published cardiovascular outcome trials (CVOTS) on oral and injectable type 2 medications. 
• Discuss approaches to combination therapy with the currently available oral agents, as well as physician and patient-directed insulin titration strategies and the basal-bolus approach.
• Outline the most up-to-date clinical information on GLP-1 receptor agonists and SGLT-2 inhibitors.
• Design a treatment plan for multiple daily injection regimens and insulin pump therapy.
• Interpret continuous glucose monitoring data.
• Select effective therapeutic adjustments based on trending or rate of change arrows, time in range, and standard deviation.
• Evaluate the physical and emotional barriers that prevent patients with diabetes from being persistent and adherent to their therapeutic regimen(s).
• Employ innovative and dynamic strategies for communication with patients to strengthen provider-patient relations and improve patient outcomes.